Home
About
FAQ
History (3)
CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy.
Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy.
Scott, Robert
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (26)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Mark C. Chappell PhD
Wake Forest School of Medicine
Why?
Avinash K. Shetty MBBS, DCH, MD
Wake Forest School of Medicine
Why?
Cristina M. Furdui PhD
Wake Forest School of Medicine
Why?
Luis F. Barroso MD
Wake Forest School of Medicine
Why?
Patricia E. Gallagher PhD
Wake Forest School of Medicine
Why?
Leslie B. Poole PhD
Wake Forest School of Medicine
Why?
Allen W. Tsang PhD
Wake Forest School of Medicine
Why?
Liliya M. Yamaleyeva MD, MS, FAHA
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 2
Next
Prev
Search Criteria
Cyclopentanes
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions